SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 9 filers reported holding SEAGEN INC in Q4 2023. The put-call ratio across all filers is 0.99 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $377,431 | -5.2% | 1,779,070 | -14.0% | 0.24% | -6.7% |
| Q2 2023 | $398,222 | +778.3% | 2,069,120 | +824.0% | 0.25% | +1100.0% |
| Q1 2023 | $45,341 | -4.3% | 223,940 | -39.2% | 0.02% | 0.0% |
| Q4 2022 | $47,358 | -99.9% | 368,506 | +18.7% | 0.02% | -54.3% |
| Q3 2022 | $42,494,000 | -21.7% | 310,550 | +1.2% | 0.05% | +39.4% |
| Q2 2022 | $54,274,000 | +200.7% | 306,739 | +144.8% | 0.03% | +135.7% |
| Q1 2022 | $18,050,000 | – | 125,298 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |